IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 50 filers reported holding IMMUNOCORE HLDGS PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,669,648 | +81.7% | 301,920 | +109.9% | 0.02% | +90.0% |
| Q2 2023 | $8,624,287 | +81.2% | 143,834 | +49.4% | 0.01% | +66.7% |
| Q1 2023 | $4,758,748 | -10.2% | 96,253 | +3.6% | 0.01% | -14.3% |
| Q4 2022 | $5,302,145 | +43.8% | 92,906 | +15.5% | 0.01% | +40.0% |
| Q3 2022 | $3,686,000 | +259.3% | 80,406 | +192.3% | 0.01% | +400.0% |
| Q2 2022 | $1,026,000 | +24.8% | 27,506 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $822,000 | -12.7% | 27,506 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $942,000 | -7.6% | 27,506 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,020,000 | +13.3% | 27,506 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $900,000 | -23.1% | 27,506 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,171,000 | – | 27,506 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $34,592,303 | 27.53% |
| RTW INVESTMENTS, LP | 6,029,633 | $361,536,795 | 6.88% |
| Paradigm Biocapital Advisors LP | 1,270,124 | $76,156,635 | 5.88% |
| Rock Springs Capital Management LP | 3,028,410 | $181,583,464 | 4.32% |
| Logos Global Management LP | 500,000 | $29,980,000 | 4.08% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $24,319,776 | 3.58% |
| GREAT POINT PARTNERS LLC | 297,082 | $17,813,037 | 3.49% |
| Eschler Asset Management LLP | 34,000 | $2,038,640 | 2.89% |
| COWEN AND COMPANY, LLC | 460,036 | $27,583,758 | 2.29% |
| HighVista Strategies LLC | 44,094 | $2,643,876 | 1.21% |